Oral ketamine: a promising treatment for restless legs syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12032026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome. A mechanism for the efficacy of this treatment is discussed.
Medical subject headings
- Excitatory Amino Acid Antagonists
- Ketamine
- Restless Legs Syndrome